GlassScriptPhysician profile
Christopher S Huot
NPI 1740217991
$1,933.03
in general payments reported to CMS, 2019-2025
23 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $147 · 2021: $193 · 2022: $366 · 2023: $734 · 2024: $145 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $365.61 | 2019-2023 | |
| Alimera Sciences, INC. | $311.47 | 2023 | Iluvien |
| Genentech USA, INC. | $293.08 | 2021-2025 | Vabysmo, Susvimo, Lucentis |
| Genentech, INC. | $128.57 | 2020 | |
| Allergan, INC. | $120.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $95.51 | 2019-2021 | |
| Abbvie INC. | $87.33 | 2022-2024 | |
| Astellas Pharma US INC | $86.71 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $63.58 | 2023-2025 | Stellaris, Xipere, Xiidra |
| Mallinckrodt Hospital Products INC. | $51.17 | 2023-2025 | Acthar |
| Omeros Corporation | $42.36 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $40.59 | 2023-2024 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $39.28 | 2023-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $32.05 | 2025 | Iluvien |
| Rayner Intraocular Lenses Limited | $31.78 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $22.91 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $22.63 | 2024 | Xdemvy |
| Harrow Eye, LLC | $21.99 | 2023 | Iheezo |
| Dompe US, INC. | $19.39 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $15.88 | 2023 | Healon Duet Pro |
| Biogen, INC. | $14.52 | 2023 | |
| Aerie Pharmaceuticals, INC. | $13.91 | 2019 | |
| Horizon Therapeutics Plc | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Huot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.